Zobrazeno 1 - 10
of 176
pro vyhledávání: '"R. Lobello"'
Autor:
Michelle Barbi de Moura, Fadel S. Alyaqoub, Gargi D. Basu, David W. Hall, Jess R Hoag, Janine R. LoBello, Frederick L. Baehner, Snehal Govind Thakkar, Steven Canfield
Publikováno v:
Journal of Clinical Oncology. 41:224-224
224 Background: Common drivers in advanced prostate cancer (PC) involve fusions of the 3’ DNA binding domain-containing region of an Erythroblast Transformation Specific (ETS) transcription factor gene with a 5’ region of another gene, often one
Autor:
Aimee Jalkanen, Gargi D. Basu, David W. Hall, Jess R Hoag, Janine R. LoBello, Frederick L. Baehner, Snehal Govind Thakkar, Tanya B. Dorff
Publikováno v:
Journal of Clinical Oncology. 41:551-551
551 Background: Some of the most common mutations seen across cancers occur in TERT, where promoter mutations upregulate TERT transcription. In bladder cancer, TERT mutations are associated with poor prognosis, especially for recurrence. In this stud
Autor:
David Driscoll, Min Wang, Fadel S. Alyaqoub, Sameer S. Udhane, Szabolcs Szelinger, Aimee Jalkanen, David W. Hall, Jess R Hoag, Janine R. LoBello, Frederick L. Baehner, Snehal Govind Thakkar, Gargi D. Basu
Publikováno v:
Journal of Clinical Oncology. 41:806-806
806 Background: BRAF V600E mutations can lead to activation of the MEK/ERK pathway. The combination of dabrafenib plus trametinib was recently FDA-approved for use in these BRAF V600E altered unresectable or metastatic cancers. BRAF non-V600 alterati
Autor:
Pawan Noel, David W. Hall, Sameer S. Udhane, Min Wang, Fadel S. Alyaqoub, Szabolcs Szelinger, Audrey A. Ozols, Janine R. LoBello, Frederick L. Baehner, Gargi D. Basu
Publikováno v:
Cancer Research. 82:1263-1263
Background: Immune-oncology (I-O) drugs show promise across multiple tumor types, and several biomarkers (BM) predict responsiveness to I-O therapy. In this descriptive study of clinical lab experience (2018-2021), we investigated the prevalence of g
Autor:
Kevin McDonnell, Gargi D. Basu, Jess W. Hoag, David W. Hall, Fadel S. Alyaqoub, Susan M. Dombrowski, Pawan Noel, Szabolcs Szelinger, Sameer S. Udhane, Min Wang, Janine R. LoBello, Snehal Govind Thakkar, Frederick L. Baehner, Christine Hong, Wai Park, Gregory Idos, Stacy W. Gray, Stephen B. Gruber
Publikováno v:
Journal of Clinical Oncology. 40:3124-3124
3124 Background: Deleterious events in DNA damage response (DDR) are hallmarks of cancer associated with sensitivity to PARP inhibitors (PARPi) and immune checkpoint inhibitors (CPI). This study investigated DDR pathway alterations across solid tumor
Autor:
Susan M. Dombrowski, Sameer S. Udhane, Gargi D. Basu, David W. Hall, Jess W. Hoag, Fadel S. Alyaqoub, Pawan Noel, Szabolcs Szelinger, Min Wang, Audrey A. Ozols, Janine R. LoBello, Snehal Govind Thakkar, Frederick L. Baehner, Joyce O'Shaughnessy
Publikováno v:
Journal of Clinical Oncology. 40:1096-1096
1096 Background: The use of targeted therapies identified using genetic and genomic approaches is now routine in breast cancer (BC). In this clinical lab experience study the frequency of actionable somatic alterations in DNA repair pathway genes ass
Autor:
Sergey V, Sheleg, Janine R, Lobello, Hugh, Hixon, Stephen W, Coons, David, Lowry, Mikhail K, Nedzved
Publikováno v:
International journal of clinical and experimental pathology. 1(3)
We investigated the dynamics of autolytic damage of the cortical neurons in adult brains for 24 hours at room temperature (+20 degrees C) after cardiac arrest. The progressive histological and ultrastructural changes were documented using routine and
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Il Giornale di chirurgia. 13(4)
Publikováno v:
Digestive and Liver Disease. 40:S191